Antineoplaston Therapy in Treating Patients With Brain Tumors
Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Current therapies for adults with persistent or recurrent brain tumors provide
very limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy
suggest that it may prove beneficial in the treatment of adults with persistent or recurrent
brain tumors.
PURPOSE: This study is being performed to determine the effects (good and bad) that
Antineoplaston therapy has on adults with persistent or recurrent brain tumors.